A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A61K 31/155 (2006.01) A61K 31/198 (2006.01)
Patent
CA 2240396
A method for the treatment and/or prophylaxis of Type II diabetes, which method comprises the administration, to a human or non-human mammal, of an effective non-toxic pharmaceutically acceptable amount of an NO synthase inhibitor, such as aminoguanidine, or a pharmaceutically acceptable derivative thereof.
L'invention concerne un procédé pour le traitement et/ou la prophylaxie du diabète de type II, ledit procédé consistant à administrer à un mammifère humain ou non, une quantité efficace, non toxique et pharmaceutiquement acceptable, d'un inhibiteur de la NO synthase, par exemple l'aminoguanidine, ou d'un dérivé pharmaceutiquement acceptable dudit inhibiteur.
Piercy Valerie
Turner Nicholas Charles
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Nitric oxide (no) synthase inhibitor to treat or prevent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide (no) synthase inhibitor to treat or prevent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide (no) synthase inhibitor to treat or prevent... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1777464